39503-57-6

Basic information

• Product Name: METHYL 5-BROMO-2-HYDROXY-4-METHYLBENZOATE
• Synonyms: METHYL 5-BROMO-2-HYDROXY-4-METHYLBENZOATE;5-Bromo-2-hydroxy-4-methylbenzoic acid methyl ester;methyl 5-bromo-4-methylsalicylate
• CAS NO: 39503-57-6
• Molecular Formula: C₉H₉BrO₃
• Molecular Weight: 245.07
• Mol File: 39503-57-6.mol
• Article Data: 10

Chemical Properties

• Melting Point: 48℃
• Appearance: /
• Density: 1.548
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: METHYL 5-BROMO-2-HYDROXY-4-METHYLBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 5-BROMO-2-HYDROXY-4-METHYLBENZOATE(39503-57-6)
• EPA Substance Registry System: METHYL 5-BROMO-2-HYDROXY-4-METHYLBENZOATE(39503-57-6)

Safety Data

• Hazardous Substances Data: 39503-57-6(Hazardous Substances Data)

Usage

General Description

Methyl 5-Bromo-2-Hydroxy-4-Methylbenzoate is a chemical compound with the molecular formula C9H9BrO3. It is a derivative of benzoic acid and is used in various organic synthesis reactions. This chemical is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs and pharmaceutical compounds. It is also used as an intermediate in the production of agrochemicals and other fine chemicals. Methyl 5-Bromo-2-Hydroxy-4-Methylbenzoate is a white to off-white crystalline solid with a molecular weight of 249.07 g/mol. It is important to handle this chemical with care as it may cause irritation to the skin, eyes, and respiratory system.

Upstream product

• 6623-35-4 5-bromo-2-hydroxy-4-methylbenzoic acid 
• 4670-56-8 methyl 2-hydroxy-4-methylbenzoate 
• 67-56-1 methanol 
• 50-85-1 2-hydroxy-p-toluic acid 
• 74-88-4 methyl iodide 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 1362819-19-9 methyl 2-acetoxy-5-bromo-4-methylbenzoate 
• 39503-58-7 methyl 5-bromo-2-methoxy-4-methylbenzoate 

Relevant articles and documents

Big catkin willow acids compounds and medical use

The invention discloses a AMPK agonist activity with salicylic acid compound and its preparation method and medical use, it is the structural formula of the formula (I) compound of formula, its pharmaceutically acceptable salt or prodrug or solvate. The structure of the invention of formula (I) compound of formula activated AMPK, therefore can be used for preparing the prevention or treatment of AMPK mediated diseases.

APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS AND USES THEREOF

Described herein are ASK1 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of blood disease, autoimmune disorders, pulmonary disorders, hypertension, inflammatory diseases, fibrotic diseases, diabetes, diabetic nephropathy, renal diseases, respiratory diseases, cardiovascular diseases, acute lung injuries, acute or chronic liver diseases, and neurodegenerative diseases.

Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors

Many diseases are believed to be driven by pathological levels of reactive oxygen species (ROS) and oxidative stress has long been recognized as a driver for inflammatory disorders. Apoptosis signal-regulating kinase 1 (ASK1) has been reported to be activ